NewsRoom Articles - Page 238 of 591

FridayAug 06, 2021 9:30 am

First Results from Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Show Marked Gains in Blood Pressure Reduction over Generic CBD Controls

Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH platform, when processed with CBD, reduces blood pressure and does so much more rapidly when compared with the generic CBD controls The complete results of the study will be produced as sample and data analyses work are completed Lexaria is…

FridayAug 06, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Sees Important Trends in Sports Medicine and Plant-Therapy

As U.S. research restrictions are lifted there is a rising interest in the use of plant-therapy in sports medicine Cannabis in sports medicine took center stage at the Tokyo Olympics American athletes are turning more and more to cannabis as a pain reliever, alternative to opioids, and part of an overall sports recovery plan RYAH Group (CSE: RYAH) (formerly RYAH Medtech), the leader in dose-control technology for plant-based medicine, works with researchers to provide a full turnkey solution for clinical studies from start to finish. RYAH Group's dose-control devices standardize the dosing protocol, QR products ensure compliance, and mobile apps…

FridayAug 06, 2021 4:20 am

420 with CNW — California Senator Asks Feds to Clarify Medical Cannabis Use Within Hospitals

The state legal cannabis industry can be a frustrating and confusing space. Despite the fact that more than 30 states have legalized medical marijuana, federal law still considers cannabis a Schedule I controlled substance with no medical applications. So while on one end nearly 5.5 million patients are using medical cannabis to alleviate a variety of medical issues, the federal government outlaws the controversial drug and requires federal agencies and institutions that rely on federal funding to follow its marijuana policies. This has been a significant issue for the past few years, with businesses and individuals finding themselves penalized by…

ThursdayAug 05, 2021 4:20 pm

420 with CNW — Study Finds That Patients with Epilepsy Who Use CBD Have Higher Quality of Life

A recent study has found that patients with epilepsy who use CBD products experienced better sleep and a higher quality of life in comparison with those who didn’t take CBD. The study, which was carried out in partnership with scientists at the Johns Hopkins University School of Medicine, was published in the “Epilepsy & Behavior” journal. The study discovered that epilepsy patients who used cannabinoid products also experienced less psychiatric symptoms, including anxiety, used fewer prescription medications generally and tolerated medications prescribed for epilepsy better. They also reported decreased healthcare use in comparison with patients in the control group. The…

ThursdayAug 05, 2021 1:17 pm

Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

GPFT forms strategic alliance with 6PAK Solutions Inc Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021 Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too (https://cnw.fm/qeAd5). “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take…

ThursdayAug 05, 2021 4:20 am

420 with CNW — Study Finds That Genetics Cause Hemp Plants to Produce More THC, Not Environmental Stresses

The use of CBD in various applications, including the treatment of depression, anxiety and pain and easing symptoms associated with cancer, has made cultivating hemp for CBD a booming industry. However, when hemp contains THC that exceeds the legal limit, the crop can test “hot.” THC is the psychoactive ingredient found in marijuana that gets a person high. Federal and state regulations classify hemp as containing no more than 0.3% THC, meaning that growers can lose their entire crop if the plants exceed the stipulated THC level. Various articles and websites have claimed that biological or environmental stresses, like crop…

WednesdayAug 04, 2021 4:20 pm

420 with CNW — Researchers Opt for Creative Ways to Study Federally Prohibited Marijuana

Since its inception, America's cannabis industry has been in a precarious position. Although 37 states have legalized medical marijuana, the federal government still classifies marijuana as a Schedule I controlled substance. This has essentially shackled the state-legal cannabis industry and has been especially detrimental to cannabis research. While cannabis is said to be effective against a wide range of medical issues, there isn't a lot of scientific data backing up these claims. Since cannabis companies aren't allowed to test their products on people before releasing them to the market, they essentially rely on customer feedback to tweak and improve products.…

WednesdayAug 04, 2021 12:06 pm

Grapefruit USA Inc. (GPFT) Expands into Billion-Dollar Market with New CBD Pet Tincture

Pet CBD industry projected to reach $1.7 billion by 2025 GPFT’s new pet CBD product targets two common dog, cat ailments: anxiety and joint pain Pets deserve the same relief that their owners experience with Grapefruit’s CBD products, says CEO Humans aren’t the only ones who may benefit from all that cannabidiol (“CBD”) offers. A recent Brightfield Group article reported that the pet CBD industry has experienced significant growth over the last several years, with Brightfield projecting an expected market valuation of more than $1.7 billion by 2025 (https://cnw.fm/drv6i). Grapefruit USA (OTCQB: GPFT) is leveraging its expertise in the space…

WednesdayAug 04, 2021 11:46 am

American Cannabis Partners Success Lies in the Details and its Values

ACP operates in two states and has strategic plans in place to expand into two more by 2024 Partnerships have allowed the recreation of the exact soil conditions, growing supplements, water makeup, and environment of Orange Hill in Jamacia Junior Gordon, the Cultivation Manager of ACP, is an award-winning and highly sought after grower whose focus is primarily on plant health The privately-owned American Cannabis Partners ("ACP"), a large scale organic cannabis cultivation company, is headquartered in Northern California but also has a foothold in Michigan. Since its beginning in 2018, ACP has acquired 12 cannabis licenses, 20,000 sq. ft of…

WednesdayAug 04, 2021 11:12 am

RYAH Group Inc. (CSE: RYAH) Supporting U.S. Changes in Cannabis Research

New cultivators have approved for federally funded studies in the U.S., and 575 DEA-licensed researchers are standing by, ready for the change RYAH's ecosystem of products allows data to be collected from seed to consumption, providing a holistic view of the plant necessary for optimal research RYAH continues to expand its global clinical and distribution network for plant-based medicine and digital patient care The U.S. is putting an end to its 50-year long prohibition on Cannabis Research (https://cnw.fm/UOoHf). New cultivators have now been approved for federally funded studies. With over 575 DEA-licensed researchers across the U.S., the future of cannabis…

News and publishing service for cannabis related companies

Contact us: 512.354.7000